title: Modifying effects of propolis on MeIQx promotion of rat hepatocarcinogenesis and in a female rat two-stage carcinogenesis model after multiple carcinogen initiation.
abstract: The modifying effects of the dietary administration of water- and ethanol-extracted propolis produced in Brazil (WB and EB, respectively) on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) promotion of rat hepatocarcinogenesis were investigated in a medium-term liver bioassay system with use of male Fischer 344 rats. The number and area of glutathione S-transferase placental form (GST-P)-positive foci in rats given 0.5% WB were significantly increased compared with the group given MeIQx alone. Furthermore, the numbers of GST-P-positive foci were higher in rats given 0.1% WB or EB than in those given the basal diet alone. The modifying effects of propolis on other organs were also examined in female Fischer 344 rats given multiple carcinogens for initiation. Rats received water- and ethanol-extracted propolis produced in Brazil and Uruguay (WB, EB, WU, and EU, respectively) in the diet after exposure to three different carcinogens. The incidence of total mammary tumors was significantly lower in rats given EU than in the control group. These results indicate that a water extract of propolis exerts a cocarcinogenic effect on MeIQx hepatocarcinogenesis while promoting the effect at low dose in a two-stage hepatocarcinogenesis model. Moreover, they suggest that ethanol-extracted propolis may be an inhibitor of mammary gland carcinogenesis.
authors.affiliation: First Department of Pathology, Nagoya City University Medical School, Nagoya 467-8601, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Kawabe
authors.forename: C
authors.initials: C
authors.lastname: Lin
authors.forename: N
authors.initials: N
authors.lastname: Kimoto
authors.forename: M
authors.initials: M
authors.lastname: Sano
authors.forename: M
authors.initials: M
authors.lastname: Hirose
authors.forename: T
authors.initials: T
authors.lastname: Shirai
mesh_terms: D000477:Alkylating Agents; D000818:Animals; D002273:Carcinogens; D004052:Diethylnitrosamine; D004195:Disease Models, Animal; D000431:Ethanol; D005260:Female; D005982:Glutathione Transferase / Q000378:metabolism; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control; D009929:Organ Size / Q000187:drug effects; D011230:Precancerous Conditions / Q000139:chemically induced; D011429:Propolis / Q000627:therapeutic use*; D011810:Quinoxalines; D011897:Random Allocation; D051381:Rats; D011916:Rats, Inbred F344; D014867:Water
chemical_list: D000477:Alkylating Agents; D002273:Carcinogens; D011810:Quinoxalines; D014867:Water; D004052:Diethylnitrosamine; D000431:Ethanol; C036990:2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline; D011429:Propolis; D005982:Glutathione Transferase